These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 1484311)
1. High-dose ifosfamide and mesna therapy in the outpatient setting. Heinzman K J Intraven Nurs; 1992; 15(6):322-6. PubMed ID: 1484311 [TBL] [Abstract][Full Text] [Related]
2. High-dose ifosfamide with mesna and granulocyte-colony-stimulating factor (recombinant human G-CSF) in patients with unresectable malignant mesothelioma. Talbot SM; Rankin C; Taub RN; Balcerzak SP; Bhoopalam N; Chapman RA; Baker LH; Middleman EL; Antman KH Cancer; 2003 Jul; 98(2):331-6. PubMed ID: 12872353 [TBL] [Abstract][Full Text] [Related]
3. A phase I study of prolonged ambulatory infusion of Ifosfamide with oral mesna. Olver I; Keefe D; Myers M; Caruso D Chemotherapy; 2005 May; 51(2-3):142-6. PubMed ID: 15886474 [TBL] [Abstract][Full Text] [Related]
7. Ifosfamide and mesna. Schoenike SE; Dana WJ Clin Pharm; 1990 Mar; 9(3):179-91. PubMed ID: 2107997 [TBL] [Abstract][Full Text] [Related]
8. Phase II study of ifosfamide and mesna in nonsquamous carcinoma of the cervix: a Gynecologic Oncology Group study. Sutton GP; Blessing JA; DiSaia PJ; McGuire WP Gynecol Oncol; 1993 Apr; 49(1):48-50. PubMed ID: 8482560 [TBL] [Abstract][Full Text] [Related]
9. Full-dose ifosfamide can be safely administered to outpatients. Meazza C; Bisogno G; Casanova M; Zanetti I; Carli M; Ferrari A Pediatr Blood Cancer; 2008 Feb; 50(2):375-8. PubMed ID: 16847930 [TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of adjuvant single-agent ifosfamide in uterine sarcoma. Kushner DM; Webster KD; Belinson JL; Rybicki LA; Kennedy AW; Markman M Gynecol Oncol; 2000 Aug; 78(2):221-7. PubMed ID: 10926807 [TBL] [Abstract][Full Text] [Related]
11. Treatment of metastatic renal cancer with ifosfamide and mesnum with and without irradiation. Fosså SD; Talle K Cancer Treat Rep; 1980; 64(10-11):1103-8. PubMed ID: 6780190 [TBL] [Abstract][Full Text] [Related]
12. Ongoing clinical studies of ifosfamide for pediatric cancer in the United States. Pratt CB Semin Oncol; 1996 Jun; 23(3 Suppl 6):84-90. PubMed ID: 8677456 [TBL] [Abstract][Full Text] [Related]
13. [Epileptic seizures and treatment with ifosfamide-mesna]. Somma-Mauvais H; Farisse P; Viallat JR Rev Neurol (Paris); 1994; 150(4):307-8. PubMed ID: 7863185 [TBL] [Abstract][Full Text] [Related]
14. Nursing implications in the administration of ifosfamide and mesna. Richters JE Oncol Nurs Forum; 1990; 17(2):276. PubMed ID: 2107534 [No Abstract] [Full Text] [Related]
15. High dose ifosfamide with mesna uroprotection. Cerny T Pathol Biol (Paris); 1993 Jan; 41(1):102. PubMed ID: 8316441 [No Abstract] [Full Text] [Related]
16. A phase II Gynecologic Oncology Group trial of ifosfamide and mesna in advanced or recurrent adenocarcinoma of the endometrium. Sutton GP; Blessing JA; DeMars LR; Moore D; Burke TW; Grendys EC Gynecol Oncol; 1996 Oct; 63(1):25-7. PubMed ID: 8898163 [TBL] [Abstract][Full Text] [Related]
17. Ifosfamide in the treatment of soft tissue sarcomas. Connelly EF; Budd GT Semin Oncol; 1996 Jun; 23(3 Suppl 6):16-21. PubMed ID: 8677442 [TBL] [Abstract][Full Text] [Related]
18. Phase II trial of ifosfamide and mesna in previously treated patients with non-Hodgkin's lymphoma: Cancer and Leukemia Group B study 8552. Case DC; Anderson J; Ervin TJ; Gottlieb A Hematol Oncol; 1991; 9(4-5):189-96. PubMed ID: 1743622 [TBL] [Abstract][Full Text] [Related]
19. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue. Hagemeister FB Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984 [TBL] [Abstract][Full Text] [Related]
20. Ifosfamide. Patient care management. Lynch MP; Ruland T Cancer Nurs; 1993 Oct; 16(5):362-5. PubMed ID: 8261384 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]